These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3861893)

  • 21. [Antileukemic action, toxicity and effects on hematopoiesis of esters of thiosulfonic acids and myleran analogs].
    Khomchenovskií EI; Boldyrev BG; Bilozor TK
    Dokl Akad Nauk SSSR; 1966 Oct; 170(6):1453-5. PubMed ID: 5241828
    [No Abstract]   [Full Text] [Related]  

  • 22. Modulation of cell competence for induction of differentiation in myeloid leukemic cells.
    Symonds G; Sachs L
    J Cell Physiol; 1982 Apr; 111(1):9-14. PubMed ID: 7045142
    [No Abstract]   [Full Text] [Related]  

  • 23. [New anthracyclines].
    Ogawa M; Ariyoshi Y
    Gan To Kagaku Ryoho; 1993 Jan; 20(1):27-33. PubMed ID: 8422185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulation by interferon of induction of differentiation of mouse myeloid leukemic cells.
    Tomida M; Yamamoto Y; Hozumi M
    Cancer Res; 1980 Aug; 40(8 Pt 1):2919-24. PubMed ID: 6155998
    [No Abstract]   [Full Text] [Related]  

  • 25. Murine myeloid leukemia: I. Pathophysiology and drug sensitivity.
    Preisler HD; Bjornsson S; Mori M
    Cancer Treat Rep; 1977 Oct; 61(7):1259-68. PubMed ID: 271044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis and biological evaluation of mitochondria targeting theranostic agents.
    Wu S; Cao Q; Wang X; Cheng K; Cheng Z
    Chem Commun (Camb); 2014 Aug; 50(64):8919-22. PubMed ID: 24976119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benzodithiophenes induce differentiation and apoptosis in human leukemia cells.
    Jing Y; Hellinger N; Xia L; Monks A; Sausville EA; Zelent A; Waxman S
    Cancer Res; 2005 Sep; 65(17):7847-55. PubMed ID: 16140954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Differentiation inducing factor of leukemia cells and antineoplastic agents].
    Hozumi M
    Nihon Rinsho; 1982; 40(8):1865-71. PubMed ID: 6755002
    [No Abstract]   [Full Text] [Related]  

  • 29. [L-asparaginase--first specific cytostatic].
    Marquardt H
    Arzneimittelforschung; 1968 Nov; 18(11):1380-6. PubMed ID: 4885156
    [No Abstract]   [Full Text] [Related]  

  • 30. Purging leukemia remission marrows with alkyl-lysophospholipids, preclinical and clinical results.
    Vogler WR; Olson AC; Berdel WE; Okamoto S; Glasser L
    Prog Clin Biol Res; 1990; 333():1-18; discussion 19-20. PubMed ID: 2308973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Management of acute leukemia in adults].
    Elonen E
    Duodecim; 1989; 105(11):987-93. PubMed ID: 2666099
    [No Abstract]   [Full Text] [Related]  

  • 32. Long-term survival and secondary acute leukemia after fotemustine therapy for metastatic melanoma.
    Gill S; Shapiro J; Westerman D; Prince HM
    J Clin Oncol; 2007 Oct; 25(28):4493-4. PubMed ID: 17906211
    [No Abstract]   [Full Text] [Related]  

  • 33. Sequential valproic acid/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemia.
    Cimino G; Lo-Coco F; Fenu S; Travaglini L; Finolezzi E; Mancini M; Nanni M; Careddu A; Fazi F; Padula F; Fiorini R; Spiriti MA; Petti MC; Venditti A; Amadori S; Mandelli F; Pelicci PG; Nervi C
    Cancer Res; 2006 Sep; 66(17):8903-11. PubMed ID: 16951208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Paramagnetic diethyleneimides of urethane phosphoric acids as antitumor agents].
    Emanuél' NM; Zhdanov RI; Konovalova NP; Vasil'eva LS; Buina NA
    Vopr Onkol; 1980; 26(5):54-8. PubMed ID: 6247836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response of acute myelomonocytic leukemia to alkyl-lysophospholipids. A case report.
    Berdel WE; Fink U; Maubach PA; Permanetter B; Rastetter J
    Blut; 1982 Mar; 44(3):177-86. PubMed ID: 6952952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor activity of N-(phosphonacetyl)-L-aspartic acid, a transition-state inhibitor of aspartate transcarbamylase.
    Johnson RK; Inouye T; Goldin A; Stark GR
    Cancer Res; 1976 Aug; 36(8):2720-5. PubMed ID: 1064466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo antitumor activity and in vitro cytotoxic properties of bis[1,2-bis(diphenylphosphino)ethane]gold(I) chloride.
    Berners-Price SJ; Mirabelli CK; Johnson RK; Mattern MR; McCabe FL; Faucette LF; Sung CM; Mong SM; Sadler PJ; Crooke ST
    Cancer Res; 1986 Nov; 46(11):5486-93. PubMed ID: 3756897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Differentiation induction of leukemic cells in acute myeloid leukemia].
    Suzuki K; Yokoyama S; Asano Y; Tomoyasu S; Tsuruoka N; Hozumi M
    Rinsho Ketsueki; 1984 Feb; 25(2):241-5. PubMed ID: 6590884
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of acute myeloblastic leukemia].
    Zittoun R
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):161-9. PubMed ID: 8337117
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on various parameters influencing leukemic cell destruction by alkyl-lysophospholipids.
    Andreesen R; Modolell M; Oepke GH; Common H; Löhr GW; Munder PG
    Anticancer Res; 1982; 2(1-2):95-100. PubMed ID: 7114806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.